Chicago, IL (PRWEB) March 07, 2014
The prescription drug safety center DrugNews.net is announcing updated information on the site for patients taking testosterone replacement therapies, or “low-T” drugs. A new study concludes the current testing methods may result in inaccurate prescription levels of the drugs*.
The report comes as the FDA has announced it will investigate the risk of heart attacks, stroke and death from low-T drugs based on recent data**.
DrugNews is a free resource for patients taking popular prescription drugs. By sharing the latest drug warnings, product recalls and lawsuit news, visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.
Last year, more than 5.5 million men filled prescriptions for low-T drugs like AndroGel, Axiron and AndroDerm***. However, recent studies question their safety.
The resource center has added a study from UCLA and the National Institute of Health finding men over 65 and those with a history of heart disease had double the rate of heart attack after starting testosterone therapy****.
In November, the American Medical Association also released data showing older men or those with prior heart disease had a 29% increased rate of heart attacks, stroke or death from low-T drugs*****.
Now, DrugNews has learned a new study by Weills Cornell Medical College questions the current methods of testing for low testosterone, and concludes that low-T drugs may be under or over-prescribed as a result*.
A number of men have already filed a testosterone lawsuit in federal court alleging drugs like AndroGel caused heart attack or stroke without warning***. Lawyers are offering help to those affected.
Anyone who suffered a heart attack or stroke after using a low-T drug like AndroGel, Axiron or AndroDerm is urged to visit DrugNews or speak with a lawyer about their legal rights as soon as possible. DrugNews only recommends lawyers who have already handled testosterone lawsuits.
For more information on the research, side effects and litigation news related to testosterone drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*Weill Cornell Medical College, 3/6/14; weill.cornell.edu/news/pr/2014/03/study-calls-for-standardization-in-measuring-testosterone-levels.html
**FDA, 1/31/14; http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
***Bloomberg, 2/5/14; bloomberg.com/news/2014-02-05/abbott-labs-sued-by-five-men-claiming-androgel-injuries.html; Aurecchia v. AbbVie Inc., 14-cv-00772, U.S. Dist. Ct, Northern District of Illinois (Chicago); Marino v. AbbVie Inc., 14-cv-00777 U.S. Dist. Ct, Northern District of Illinois (Chicago)
****Public Library of Science, 1/29/14; plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805
*****JAMA 11/5/13; media.jamanetwork.com/news-item/testosterone-therapy-following-coronary-angiography-associated-increased-risk-adverse-outcomes/